Seok-Gu Kang - Search Results

Year	Number of Results
2004	1
2005	3
2006	8
2007	6
2008	2
2009	4
2010	4
2011	4
2012	4
2013	12
2014	4
2015	5
2016	16
2017	12
2018	15
2019	19
2020	26
2021	25
2022	23
2023	13
2024	5

1

Comparison of Glioblastoma Cell Culture Platforms Based on Transcriptional Similarity with Paired Tissue.

Park J, Koh I, Cha J, Oh Y, Shim JK, Kim H, Moon JH, Kim EH, Chang JH, Kim P, Kang SG. Park J, et al. Among authors: kang sg. Pharmaceuticals (Basel). 2024 Apr 19;17(4):529. doi: 10.3390/ph17040529. Pharmaceuticals (Basel). 2024. PMID: 38675489 Free PMC article.

2

High Radiation Dose to the Fornix Causes Symptomatic Radiation Necrosis in Patients with Anaplastic Oligodendroglioma.

Kim TH, Cho J, Kang SG, Moon JH, Suh CO, Park YW, Chang JH, Yoon HI. Kim TH, et al. Among authors: kang sg. Yonsei Med J. 2024 Jan;65(1):1-9. doi: 10.3349/ymj.2023.0112. Yonsei Med J. 2024. PMID: 38154474 Free PMC article.

3

Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment.

Kim D, Ko HY, Chung JI, Park YM, Lee S, Kim SY, Kim J, Chun JH, Han KS, Lee M, Ju YH, Park SJ, Park KD, Nam MH, Kim SH, Shim JK, Park Y, Lim H, Park J, Lee GH, Kim H, Kim S, Park U, Ryu H, Lee SY, Park S, Kang SG, Chang JH, Lee CJ, Yun M. Kim D, et al. Among authors: kang sg. Neuro Oncol. 2024 May 3;26(5):843-857. doi: 10.1093/neuonc/noad243. Neuro Oncol. 2024. PMID: 38085571

4

11 C-Acetate PET/CT for Reactive Astrogliosis Outperforms 11 C-Methionine PET/CT in Glioma Classification and Survival Prediction.

Kim D, Yi JH, Park Y, Kim SJ, Kang SG, Kim SH, Chun JH, Chang JH, Yun M. Kim D, et al. Among authors: kang sg. Clin Nucl Med. 2024 Feb 1;49(2):109-115. doi: 10.1097/RLU.0000000000004991. Epub 2023 Dec 4. Clin Nucl Med. 2024. PMID: 38049976

5

Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.

Kim N, Lee J, Nam DH, Lee JI, Seol HJ, Kong DS, Choi JW, Chong K, Lee WJ, Chang JH, Kang SG, Moon JH, Cho J, Lim DH, Yoon HI. Kim N, et al. Among authors: kang sg. J Neurooncol. 2023 Nov;165(2):269. doi: 10.1007/s11060-023-04498-x. J Neurooncol. 2023. PMID: 37938445 No abstract available.

6

Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.

Kim N, Lee J, Nam DH, Lee JI, Seol HJ, Kong DS, Choi JW, Chong K, Lee WJ, Chang JH, Kang SG, Moon JH, Cho J, Lim DH, Yoon HI. Kim N, et al. Among authors: kang sg. J Neurooncol. 2023 Nov;165(2):261-268. doi: 10.1007/s11060-023-04465-6. Epub 2023 Oct 20. J Neurooncol. 2023. PMID: 37861921

7

Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype.

Sohn B, Park K, Ahn SS, Park YW, Choi SH, Kang SG, Kim SH, Chang JH, Lee SK. Sohn B, et al. Among authors: kang sg. J Neurooncol. 2023 Sep;164(2):341-351. doi: 10.1007/s11060-023-04435-y. Epub 2023 Sep 10. J Neurooncol. 2023. PMID: 37689596

8

Rethinking extent of resection of contrast-enhancing and non-enhancing tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification.

Park YW, Kim S, Han K, Ahn SS, Moon JH, Kim EH, Kim J, Kang SG, Kim SH, Lee SK, Chang JH. Park YW, et al. Among authors: kang sg. Eur Radiol. 2024 Feb;34(2):1376-1387. doi: 10.1007/s00330-023-10125-0. Epub 2023 Aug 23. Eur Radiol. 2024. PMID: 37608093

9

Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program.

Park J, Shim JK, Lee M, Kim D, Yoon SJ, Moon JH, Kim EH, Park JY, Chang JH, Kang SG. Park J, et al. Among authors: kang sg. Br J Cancer. 2023 Oct;129(7):1061-1070. doi: 10.1038/s41416-023-02391-y. Epub 2023 Aug 9. Br J Cancer. 2023. PMID: 37558923 Free PMC article.

10

The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Survey About Specific Clinical Scenarios (Version 2023.1).

Kim MS, Go SI, Wee CW, Lee MH, Kang SG, Go KO, Kwon SM, Kim W, Dho YS, Park SH, Seo Y, Song SW, Ahn S, Oh HJ, Yoon HI, Lee SW, Lee JH, Cho KR, Choi JW, Hong JB, Hwang K, Park CK, Lim DH; KSNO Guideline Working Group. Kim MS, et al. Among authors: kang sg. Brain Tumor Res Treat. 2023 Apr;11(2):133-139. doi: 10.14791/btrt.2023.0010. Brain Tumor Res Treat. 2023. PMID: 37151155 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

179 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year